Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-03

Clinical Trial Update: Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation [Phase 1, Phase 2]

View source ↗

Summary

Early-stage clinical trial updates are reported for an electrostimulation approach to treat optic nerve damage in glaucoma, covering Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Magdeburg | Conditions: Glaucoma, Electrical Stimulation | Phase 1, Phase 2 | Status: UNKNOWN